Date published: 2026-3-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

Rab 32 Inhibitors

Rab 32 inhibitors are a class of compounds that interact with Rab 32 or its associated pathways to modulate its activity within the cell. These inhibitors may exert their effects by directly targeting Rab 32 or by influencing the numerous cellular processes that Rab 32 is involved with. Due to the central role of Rab 32 in vesicular trafficking and membrane fusion, compounds that affect these cellular processes can, by extension, modulate the function of Rab 32. The inhibitory actions of these compounds encompass a broad range of mechanisms, from altering enzyme activities that participate in Rab 32 activation, such as tyrosine kinases and lipid kinases, to affecting the cytoskeletal dynamics and membrane trafficking machinery that Rab 32 is associated with.

The molecules that fall into the category of Rab 32 inhibitors display diverse chemical structures and properties, reflecting the various mechanisms by which they impact Rab 32 activity. These compounds are not uniform in their action but are unified by the outcome of their activity, which is the modulation of Rab 32 function. By interfering with upstream signaling pathways, these chemicals can alter the phosphorylation patterns of proteins related to Rab 32, change the lipid composition of membranes where Rab 32 operates, or modify the cytoskeletal elements that are necessary for Rab 32-mediated vesicular transport. Each chemical exhibits specificity in its mode of action, contributing to the collective ability to influence Rab 32 activity within the cell.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

A phosphoinositide 3-kinase inhibitor that can disrupt signaling pathways influencing Rab 32-mediated vesicular trafficking.

Simvastatin

79902-63-9sc-200829
sc-200829A
sc-200829B
sc-200829C
50 mg
250 mg
1 g
5 g
$31.00
$89.00
$135.00
$443.00
13
(1)

An HMG-CoA reductase inhibitor that affects cholesterol biosynthesis, potentially altering membrane composition and Rab 32 localization.

Taxol

33069-62-4sc-201439D
sc-201439
sc-201439A
sc-201439E
sc-201439B
sc-201439C
1 mg
5 mg
25 mg
100 mg
250 mg
1 g
$41.00
$74.00
$221.00
$247.00
$738.00
$1220.00
39
(2)

A microtubule-stabilizing agent that can disrupt intracellular transport, indirectly affecting Rab 32-related processes.

Nocodazole

31430-18-9sc-3518B
sc-3518
sc-3518C
sc-3518A
5 mg
10 mg
25 mg
50 mg
$59.00
$85.00
$143.00
$247.00
38
(2)

A microtubule-depolymerizing agent that can perturb Rab 32-associated vesicle transport.

ML 141

71203-35-5sc-362768
sc-362768A
5 mg
25 mg
$137.00
$512.00
7
(1)

A Cdc42 inhibitor that may disrupt downstream effects of Rab 32 in cytoskeletal organization.

PKF118-310

84-82-2sc-364590
sc-364590A
5 mg
25 mg
$180.00
$651.00
(1)

A protein kinase inhibitor that could impair phosphorylation states of proteins interacting with Rab 32.

SecinH3

853625-60-2sc-203260
5 mg
$278.00
6
(1)

An inhibitor of cytohesins, affecting ARF proteins and potentially altering Rab 32-related trafficking.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

An inhibitor of ADP-ribosylation factor (ARF), which could modulate Rab 32 activity by impacting vesicle formation.

Gö 6976

136194-77-9sc-221684
500 µg
$227.00
8
(1)

A protein kinase C inhibitor that can alter signaling cascades related to Rab 32's function.

Dynamin Inhibitor I, Dynasore

304448-55-3sc-202592
10 mg
$89.00
44
(2)

A GTPase inhibitor of dynamin that could affect endocytosis and vesicle trafficking involving Rab 32.